Arrhythmogenic right ventricular dysplasia epidemiology and demographics: Difference between revisions
Hudakarman (talk | contribs) No edit summary |
Hudakarman (talk | contribs) |
||
Line 24: | Line 24: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Electrophysiology]] | [[Category:Electrophysiology]] |
Revision as of 17:52, 6 May 2020
Arrhythmogenic right ventricular dysplasia Microchapters |
Differentiating Arrhythmogenic right ventricular dysplasia from other Diseases |
---|
Diagnosis |
Treatment |
Arrhythmogenic right ventricular dysplasia epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Arrhythmogenic right ventricular dysplasia epidemiology and demographics |
FDA on Arrhythmogenic right ventricular dysplasia epidemiology and demographics |
CDC on Arrhythmogenic right ventricular dysplasia epidemiology and demographics |
Arrhythmogenic right ventricular dysplasia epidemiology and demographics in the news |
Blogs onArrhythmogenic right ventricular dysplasia epidemiology and demographics |
Directions to Hospitals Treating Arrhythmogenic right ventricular dysplasia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
ARVD is rare, is observed more commonly in males, and accounts for 17% of all sudden cardiac deaths in the young.
Epidemiology and demographics
Incidence
The incidence of ARVD is about 1/10,000 in the general population in the United States, although some studies have suggested that it may be as common as 1/1,000. It accounts for up to 17% of all sudden cardiac deaths in the young. In Italy, the incidence is 40/10,000, making it the most common cause of sudden cardiac death in the young population. It is more common in Northern Italy.
Gender
Male to female ratio of 3:1